ArticleBlood advances2022
Ferrari N, Ward G, Gewinner C, et al. Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma. Blood Adv. 2021;5(20):4003-4016.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.